tiprankstipranks
Tianda Pharmaceuticals Ltd. (HK:0455)
:0455
Hong Kong Market
0455
Tianda Pharmaceuticals Ltd.
RESEARCH TOOLSreports

Tianda Pharmaceuticals Ltd. (0455) Ratios

0 Followers

Tianda Pharmaceuticals Ltd. Ratios

HK:0455's free cash flow for Q2 2024 was HK$0.49. For the 2024 fiscal year, HK:0455's free cash flow was decreased by HK$ and operating cash flow was HK$-0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Mar 21
Liquidity Ratios
Current Ratio
 0.83 0.86 1.10 1.54 2.13
Quick Ratio
 0.64 0.70 0.89 1.41 1.85
Cash Ratio
 0.27 0.34 0.52 0.94 1.23
Solvency Ratio
 -0.24 -0.24 0.04 -0.01 <0.01
Operating Cash Flow Ratio
 -0.04 -0.04 -0.16 0.22 -0.03
Short-Term Operating Cash Flow Coverage
 -0.11 -0.08 -0.52 1.22 -0.14
Net Current Asset Value
HK$ -93.80MHK$ -43.48MHK$ 18.86MHK$ 123.95MHK$ 202.37M
Leverage Ratios
Debt-to-Assets Ratio
 0.18 0.17 0.12 0.13 0.14
Debt-to-Equity Ratio
 0.29 0.25 0.19 0.22 0.21
Debt-to-Capital Ratio
 0.23 0.20 0.16 0.18 0.17
Long-Term Debt-to-Capital Ratio
 0.08 0.00 0.01 0.09 0.11
Financial Leverage Ratio
 1.64 1.51 1.55 1.73 1.54
Debt Service Coverage Ratio
 -0.61 -0.44 0.16 -0.21 0.02
Interest Coverage Ratio
 -15.31 -11.16 -5.87 -9.37 -53.74
Debt to Market Cap
 0.62 0.34 0.22 0.15 0.30
Interest Debt Per Share
 0.06 0.06 0.06 0.07 0.07
Net Debt to EBITDA
 -1.25 -0.84 -3.12 10.01 33.74
Profitability Margins
Gross Profit Margin
41.28%46.08%48.02%46.01%47.30%
EBIT Margin
-16.75%-15.00%-3.90%-12.83%-5.35%
EBITDA Margin
-16.75%-15.00%2.94%-3.64%-1.01%
Operating Profit Margin
-16.75%-16.41%-5.45%-12.83%-7.64%
Pretax Profit Margin
-21.47%-16.47%-4.83%-11.68%-5.49%
Net Profit Margin
-21.67%-18.60%-4.54%-9.99%-4.25%
Continuous Operations Profit Margin
-21.75%-18.61%-4.70%-10.79%-4.25%
Net Income Per EBT
100.96%112.94%94.01%85.56%77.36%
EBT Per EBIT
128.17%100.35%88.53%91.03%71.89%
Return on Assets (ROA)
-9.36%-8.02%-2.63%-5.02%-1.86%
Return on Equity (ROE)
-14.55%-12.13%-4.08%-8.70%-2.86%
Return on Capital Employed (ROCE)
-10.62%-10.53%-4.81%-9.66%-4.37%
Return on Invested Capital (ROIC)
-9.07%-8.48%-4.00%-8.14%-3.16%
Return on Tangible Assets
-11.68%-9.99%-2.94%-5.54%-2.09%
Earnings Yield
-33.56%-16.89%-5.15%-6.27%-4.33%
Efficiency Ratios
Receivables Turnover
 4.22 4.23 5.00 3.83 0.00
Payables Turnover
 2.39 2.64 2.34 4.14 2.56
Inventory Turnover
 4.24 4.42 4.25 6.12 3.59
Fixed Asset Turnover
 0.80 0.85 1.29 1.36 1.12
Asset Turnover
 0.43 0.43 0.58 0.50 0.44
Working Capital Turnover Ratio
 -8.52 -156.15 4.70 2.18 1.46
Cash Conversion Cycle
 19.87 30.52 3.23 66.73 -41.13
Days of Sales Outstanding
 86.49 86.38 72.97 95.35 0.00
Days of Inventory Outstanding
 86.01 82.49 85.98 59.59 101.72
Days of Payables Outstanding
 152.64 138.35 155.73 88.22 142.85
Operating Cycle
 172.51 168.87 158.95 154.95 101.72
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 -0.02 0.04 >-0.01
Free Cash Flow Per Share
 -0.02 -0.02 -0.05 0.03 -0.03
CapEx Per Share
 0.02 0.02 0.03 0.01 0.03
Free Cash Flow to Operating Cash Flow
 5.39 5.39 2.33 0.69 7.54
Dividend Paid and CapEx Coverage Ratio
 -0.20 -0.20 -0.69 1.88 -0.13
Capital Expenditure Coverage Ratio
 -0.23 -0.23 -0.75 3.24 -0.15
Operating Cash Flow Coverage Ratio
 -0.07 -0.08 -0.44 0.56 -0.05
Operating Cash Flow to Sales Ratio
 -0.03 -0.03 -0.09 0.14 -0.02
Free Cash Flow Yield
-25.08%-14.39%-24.76%6.29%-12.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.98 -5.92 -19.40 -15.94 -23.11
Price-to-Sales (P/S) Ratio
 0.65 1.10 0.88 1.59 0.98
Price-to-Book (P/B) Ratio
 0.46 0.72 0.79 1.39 0.66
Price-to-Free Cash Flow (P/FCF) Ratio
 -3.99 -6.95 -4.04 15.91 -8.08
Price-to-Operating Cash Flow Ratio
 -21.50 -37.47 -9.42 11.01 -60.90
Price-to-Earnings Growth (PEG) Ratio
 0.10 -0.04 0.35 -0.11 1.40
Price-to-Fair Value
 0.46 0.72 0.79 1.39 0.66
Enterprise Value Multiple
 -5.11 -8.19 26.81 -33.75 -63.65
Enterprise Value
 276.40M 405.11M 419.86M 671.54M 327.39M
EV to EBITDA
 -5.11 -8.19 26.81 -33.75 -63.65
EV to Sales
 0.86 1.23 0.79 1.23 0.64
EV to Free Cash Flow
 -5.28 -7.75 -3.62 12.27 -5.28
EV to Operating Cash Flow
 -28.50 -41.77 -8.44 8.49 -39.80
Tangible Book Value Per Share
 0.14 0.16 0.23 0.26 0.31
Shareholders’ Equity Per Share
 0.21 0.24 0.28 0.29 0.35
Tax and Other Ratios
Effective Tax Rate
 -0.01 -0.13 0.03 0.08 0.23
Revenue Per Share
 0.15 0.15 0.25 0.25 0.24
Net Income Per Share
 -0.03 -0.03 -0.01 -0.03 -0.01
Tax Burden
 1.01 1.13 0.94 0.86 0.77
Interest Burden
 1.28 1.10 1.24 0.91 1.03
Research & Development to Revenue
 0.03 0.04 0.02 0.07 0.03
SG&A to Revenue
 0.55 0.58 0.16 0.15 0.14
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.18 0.18 2.06 -1.45 0.29
Currency in HKD